⌘K

Login Start Free

Home/Filings/4/0001209191-24-002429

4//SEC Filing

Aghion Daniel 4

Accession 0001209191-24-002429

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 5:30 PM ET

Size

5.1 KB

Accession

0001209191-24-002429

Insider Transaction Report

Form 4

Period: 2024-01-30

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Award
Common Stock
2024-01-30+3,750→ 38,820 total

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 937 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0002004805

Filing Metadata

Form type: 4
Filed: Jan 29, 7:00 PM ET
Accepted: Jan 30, 5:30 PM ET
Size: 5.1 KB

View on SEC.gov